<!doctype html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <title>Abnormal uterine bleeding — DGRefHelp Drafts</title>
  <link rel="stylesheet" href="../assets/site.css" />
</head>
<body>
  <div class="container">
    <div class="header">
      <div class="brand">
        <h1><a href="../index.html">DGRefHelp drafts</a> / Abnormal uterine bleeding</h1>
        <div class="sub">IMB/PCB/irregular bleeding (non-pregnant) → GP workup + when to refer. Includes referral-letter triage metrics (D&amp;G).</div>
      </div>
      <div class="badges">
        <div class="badge">Mode: quick</div>
        <div class="badge">Last updated: 2026‑02‑11</div>
      </div>
    </div>

    <div class="grid">
      <div class="card">
        <div class="card-hd">
          <div class="tabs" data-tabs>
            <button class="tab" role="tab" data-tab="evidence" aria-selected="true">Evidence</button>
            <button class="tab" role="tab" data-tab="draft" aria-selected="false">DGRefHelp draft</button>
            <button class="tab" role="tab" data-tab="refs" aria-selected="false">References</button>
          </div>
          <div class="copybar">
            <button class="btn" data-copy-target="#draftText">Copy draft</button>
            <button class="btn" data-copy-target="#evidenceText">Copy evidence</button>
          </div>
        </div>

        <div class="card-bd">
          <div class="panel active" role="tabpanel" data-panel="evidence">
            <div id="evidenceText" class="section">
              <h3>Evidence summary (triangulated)</h3>

              <div class="callout">
                <strong>Related pages</strong>
                <div class="small">
                  <ul>
                    <li><a href="./postcoital-bleeding.html">Postcoital bleeding</a> (if PCB is the main symptom).</li>
                    <li><a href="./symptomatic-colposcopy.html">Symptoms suggestive of cervical cancer (PCB/discharge) — referral &amp; colposcopy</a> (if cervix/vagina/vulva looks suspicious or symptoms concerning despite up-to-date screening).</li>
                    <li><a href="./heavy-menstrual-bleeding.html">Heavy menstrual bleeding</a> (if the main issue is heavy/prolonged bleeding with regular cycles).</li>
                    <li><a href="./postmenopausal-bleeding.html">Postmenopausal bleeding</a> (if established postmenopausal).</li>
                  </ul>
                </div>
              </div>

              <div class="callout ok">
                <strong>Key pathway design points</strong>
                <ul>
                  <li>Abnormal uterine bleeding (AUB) is a <strong>symptom group</strong>; priority is to identify who needs <strong>urgent exclusion of malignancy</strong> (endometrial/cervical) versus who can start primary care management.</li>
                  <li>NICE NG88 (HMB) gives clear triggers for considering <strong>endometrial pathology</strong> (risk factors / treatment failure) and recommends targeted sampling in the context of hysteroscopy (not blind biopsy for HMB).</li>
                  <li>Local DGRefHelp pages should make explicit what information secondary care needs for triage (age, BMI, bleeding pattern, PCB/IMB, tamoxifen, PCOS/obesity, exam findings, treatments tried).</li>
                </ul>
              </div>

              <h4>NICE NG88 (used here for endometrial pathology risk framing)</h4>
              <ul>
                <li>Risk features for endometrial pathology that should prompt escalation include: persistent intermenstrual/irregular bleeding; infrequent heavy bleeding in obese women or those with PCOS; tamoxifen use; and treatment failure.</li>
                <li>Investigation choice should be guided by history/exam: hysteroscopy for suspected submucosal fibroid/polyp/endometrial pathology; ultrasound for palpable uterus/pelvic mass/inconclusive exam.</li>
              </ul>

              <div class="callout warn">
                <strong>Local agreement needed</strong>
                <ul>
                  <li>Confirm the local D&amp;G thresholds and referral routes for <strong>postcoital bleeding</strong>, abnormal cervix findings, and suspected endometrial pathology in pre/perimenopausal women (these are often board-specific).</li>
                  <li>Confirm whether D&amp;G expects primary care to arrange ultrasound before gynae referral in specific scenarios (vs gynae arranging).</li>
                </ul>
              </div>
            </div>
          </div>

          <div class="panel" role="tabpanel" data-panel="draft">

            <div class="callout" style="margin-bottom:12px">
              <strong>Copy/paste HTML for Right Decisions accordion sections</strong>
              <div class="small">These snippets contain section content only (no internal headings). Paste each into the matching accordion section.</div>
              <div style="height:10px"></div>
              <div class="copybar" style="justify-content:flex-start">
                <button class="btn" data-copy-target="#htmlBackground">Copy Background HTML</button>
                <button class="btn" data-copy-target="#htmlAssessment">Copy Assessment HTML</button>
                <button class="btn" data-copy-target="#htmlPCM">Copy Primary care mgmt HTML</button>
                <button class="btn" data-copy-target="#htmlRefer">Copy Who to refer HTML</button>
                <button class="btn" data-copy-target="#htmlNotRefer">Copy Who not to refer HTML</button>
                <button class="btn" data-copy-target="#htmlRefs">Copy References HTML</button>
              </div>

              <details style="margin-top:10px">
                <summary class="small" style="cursor:pointer">Show HTML snippets</summary>

                <h4 style="margin:12px 0 6px">Background (HTML)</h4>
                <pre id="htmlBackground">&lt;ul&gt;
  &lt;li&gt;Abnormal uterine bleeding (AUB) includes intermenstrual bleeding (IMB), postcoital bleeding (PCB), irregular/unpredictable bleeding and persistent change in bleeding pattern (non-pregnant).&lt;/li&gt;
  &lt;li&gt;Priorities: exclude pregnancy where relevant, consider infection/cervical pathology, and identify those needing urgent exclusion of endometrial/cervical malignancy.&lt;/li&gt;
&lt;/ul&gt;</pre>

                <h4 style="margin:12px 0 6px">Assessment (primary care) (HTML)</h4>
                <pre id="htmlAssessment">&lt;ul&gt;
  &lt;li&gt;&lt;strong&gt;History:&lt;/strong&gt; bleeding pattern (IMB/PCB, frequency, duration, volume), pain, discharge, contraception/HRT, cervical screening history, pregnancy risk, anticoagulants, tamoxifen.&lt;/li&gt;
  &lt;li&gt;&lt;strong&gt;Risk factors (endometrial pathology):&lt;/strong&gt; age &amp;gt;45 with new/increased bleeding; persistent IMB/irregular bleeding; obesity/BMI &amp;gt;30; PCOS; tamoxifen; treatment failure.&lt;/li&gt;
  &lt;li&gt;&lt;strong&gt;Examination:&lt;/strong&gt; speculum exam if PCB/discharge or cervix concern; bimanual/pelvic exam if pain/pressure symptoms or structural cause suspected.&lt;/li&gt;
  &lt;li&gt;&lt;strong&gt;Tests (typical primary care):&lt;/strong&gt; pregnancy test if relevant; FBC if heavy/prolonged bleeding; STI testing if risk/discharge; consider TSH only if clinically indicated.&lt;/li&gt;
&lt;/ul&gt;</pre>

                <h4 style="margin:12px 0 6px">Primary care management (HTML)</h4>
                <pre id="htmlPCM">&lt;ul&gt;
  &lt;li&gt;Treat contributory causes where identified (e.g., STI/cervicitis).&lt;/li&gt;
  &lt;li&gt;If low risk of structural/histological abnormality, consider primary care medical management (overlaps with HMB options).&lt;/li&gt;
  &lt;li&gt;If structural cause suspected (pelvic mass/uterus palpable), arrange ultrasound as per local process.&lt;/li&gt;
&lt;/ul&gt;</pre>

                <h4 style="margin:12px 0 6px">Who to refer (HTML)</h4>
                <pre id="htmlRefer">&lt;ul&gt;
  &lt;li&gt;&lt;strong&gt;Suspected cervical cancer&lt;/strong&gt;: abnormal cervix/visible lesion, contact bleeding with suspicious cervix → urgent pathway / colposcopy route per local process (state findings clearly).&lt;/li&gt;
  &lt;li&gt;&lt;strong&gt;Suspected endometrial pathology&lt;/strong&gt;: persistent IMB/irregular bleeding with risk factors (age &amp;gt;45, obesity/PCOS, tamoxifen) or treatment failure → gynaecology for further assessment (often hysteroscopy-based).&lt;/li&gt;
  &lt;li&gt;&lt;strong&gt;Structural abnormality suspected&lt;/strong&gt; (uterus palpable/pelvic mass) or abnormal scan findings → gynaecology referral with imaging report.&lt;/li&gt;
&lt;/ul&gt;

&lt;p class=&quot;small&quot;&gt;&lt;strong&gt;Referral letter: required information (triage metrics)&lt;/strong&gt;&lt;/p&gt;
&lt;ul&gt;
  &lt;li&gt;Age, BMI (if known), parity; pregnancy risk and pregnancy test result if relevant.&lt;/li&gt;
  &lt;li&gt;Bleeding pattern: IMB/PCB/irregular; duration; severity; impact; any anaemia symptoms.&lt;/li&gt;
  &lt;li&gt;Cervical screening history (date/result) and speculum findings (normal vs lesion/contact bleeding).&lt;/li&gt;
  &lt;li&gt;Risk factors: PCOS/obesity, tamoxifen, anticoagulation, family history (if relevant).&lt;/li&gt;
  &lt;li&gt;Treatments tried and response (incl CHC/progestogens/LNG‑IUS where relevant).&lt;/li&gt;
  &lt;li&gt;Results: FBC; STI tests if done; ultrasound report if performed.&lt;/li&gt;
&lt;/ul&gt;</pre>

                <h4 style="margin:12px 0 6px">Who not to refer (HTML)</h4>
                <pre id="htmlNotRefer">&lt;ul&gt;
  &lt;li&gt;Low-risk bleeding patterns with no risk factors and normal examination may be managed initially in primary care with safety-netting (confirm locally).&lt;/li&gt;
&lt;/ul&gt;</pre>

                <h4 style="margin:12px 0 6px">References (HTML)</h4>
                <pre id="htmlRefs">&lt;ol&gt;
  &lt;li&gt;NICE NG88: Heavy menstrual bleeding: assessment and management (risk features for endometrial pathology; investigations). https://www.nice.org.uk/guidance/ng88 (retrieved 2026‑02‑08)&lt;/li&gt;
  &lt;li&gt;NICE NG12: Suspected cancer (gynaecological sections; cervical/endometrial criteria vary by pathway). https://www.nice.org.uk/guidance/ng12/chapter/Recommendations-organised-by-site-of-cancer (retrieved 2026‑02‑08)&lt;/li&gt;
&lt;/ol&gt;</pre>
              </details>
            </div>

            <div id="draftText" class="section">
              <h3>Abnormal uterine bleeding (AUB)</h3>

              <div class="callout" style="margin:10px 0 12px">
                <strong>Related pages</strong>
                <div class="small">
                  <ul>
                    <li><a href="./postcoital-bleeding.html">Postcoital bleeding</a></li>
                    <li><a href="./symptomatic-colposcopy.html">Symptoms suggestive of cervical cancer (PCB/discharge) — referral &amp; colposcopy</a></li>
                    <li><a href="./heavy-menstrual-bleeding.html">Heavy menstrual bleeding</a></li>
                    <li><a href="./postmenopausal-bleeding.html">Postmenopausal bleeding</a></li>
                  </ul>
                </div>
              </div>

              <h4>Background</h4>
              <ul>
                <li>Includes intermenstrual bleeding (IMB), postcoital bleeding (PCB), irregular/unpredictable bleeding and persistent change in bleeding pattern (non-pregnant).</li>
                <li>Priorities: exclude pregnancy where relevant; consider infection/cervical pathology; identify those needing urgent exclusion of endometrial/cervical malignancy.</li>
              </ul>

              <h4>Assessment (primary care) — collapsible</h4>
              <ul>
                <li><strong>History:</strong> bleeding pattern (IMB/PCB, frequency, duration, volume), pain, discharge, contraception/HRT, cervical screening history, pregnancy risk, anticoagulants, tamoxifen.</li>
                <li><strong>Risk factors (endometrial pathology):</strong> age &gt;45 with new/increased bleeding; persistent IMB/irregular bleeding; obesity/BMI &gt;30; PCOS; tamoxifen; treatment failure.</li>
                <li><strong>Examination:</strong> speculum exam if PCB/discharge or cervix concern; bimanual/pelvic exam if pain/pressure symptoms or structural cause suspected.</li>
                <li><strong>Tests:</strong> pregnancy test if relevant; FBC if heavy/prolonged bleeding; STI testing if risk/discharge; consider TSH only if clinically indicated.</li>
              </ul>

              <h4>Primary care management</h4>
              <ul>
                <li>Treat contributory causes where identified (e.g., STI/cervicitis).</li>
                <li>If low risk of structural/histological abnormality, consider primary care medical management (see HMB page for options) + safety-netting.</li>
                <li>If structural cause suspected (pelvic mass/uterus palpable), arrange ultrasound as per local process.</li>
              </ul>

              <h4>Who to refer</h4>
              <p class="small">Include the metrics secondary care needs for triage (bleeding pattern, risk factors, exam findings, tests done, treatments tried).</p>
              <ul>
                <li><strong>Suspected cervical cancer</strong>: abnormal cervix/visible lesion, contact bleeding with suspicious cervix → urgent pathway / colposcopy route per local process (state findings clearly).</li>
                <li><strong>Suspected endometrial pathology</strong>: persistent IMB/irregular bleeding with risk factors (age &gt;45, obesity/PCOS, tamoxifen) or treatment failure → gynaecology for further assessment (often hysteroscopy-based).</li>
                <li><strong>Structural abnormality suspected</strong> (uterus palpable/pelvic mass) or abnormal scan findings → gynaecology referral with imaging report.</li>
              </ul>

              <h4>Referral letter: required information (triage metrics)</h4>
              <ul>
                <li>Age, BMI (if known), parity; pregnancy risk and pregnancy test result if relevant.</li>
                <li>Bleeding pattern: IMB/PCB/irregular; duration; severity; impact; any anaemia symptoms.</li>
                <li>Cervical screening history (date/result) and speculum findings (normal vs lesion/contact bleeding).</li>
                <li>Risk factors: PCOS/obesity, tamoxifen, anticoagulation, family history (if relevant).</li>
                <li>Treatments tried and response (incl CHC/progestogens/LNG‑IUS where relevant).</li>
                <li>Results: FBC; STI tests if done; ultrasound report if performed.</li>
              </ul>

              <h4>Who not to refer</h4>
              <ul>
                <li>Low-risk bleeding patterns with no risk factors and normal examination may be managed initially in primary care with safety-netting (confirm locally).</li>
              </ul>

              <h4>Local agreement needed (drafting-site only)</h4>
              <ul>
                <li><label><input type="checkbox" disabled /> Confirm the local D&amp;G thresholds and referral routes for PCB and abnormal cervix findings (often direct-to colposcopy).</label></li>
                <li><label><input type="checkbox" disabled /> Confirm local referral routes for suspected endometrial pathology in pre/perimenopausal women (direct-to hysteroscopy clinic vs general gynae).</label></li>
                <li><label><input type="checkbox" disabled /> Confirm what imaging/tests are expected before referral (ultrasound access model).</label></li>
              </ul>
            </div>
          </div>

          <div class="panel" role="tabpanel" data-panel="refs">
            <div class="section">
              <h3>References</h3>
              <ol>
                <li>NICE NG88: Heavy menstrual bleeding: assessment and management. <a href="https://www.nice.org.uk/guidance/ng88">https://www.nice.org.uk/guidance/ng88</a> (retrieved 2026‑02‑08)</li>
                <li>NICE NG12: Suspected cancer — recommendations organised by site of cancer. <a href="https://www.nice.org.uk/guidance/ng12/chapter/Recommendations-organised-by-site-of-cancer">https://www.nice.org.uk/guidance/ng12/chapter/Recommendations-organised-by-site-of-cancer</a> (retrieved 2026‑02‑08)</li>
              </ol>
            </div>
          </div>

        </div>
      </div>
    </div>
  </div>

  <script src="../assets/site.js"></script>
</body>
</html>
